ACUTE MONOCYTIC LEUKEMIA
Clinical trials for ACUTE MONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo tackles tough leukemia
Disease control Recruiting nowThis study tests a new mix of drugs for people newly diagnosed with a specific type of acute myeloid leukemia (AML). The treatment combines a targeted drug (venetoclax) with two chemotherapy drugs, then switches to another chemo drug plus venetoclax. The goal is to see if this ap…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New leukemia combo aims for higher remission rates
Disease control Recruiting nowThis study compares two treatments for acute monocytic leukemia, a blood cancer. About 204 people aged 14 to 60 will get either a new drug combo (venetoclax plus CACAG) or standard chemotherapy (3+7). The goal is to see which approach leads to more complete remissions after one c…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called STX-0712 in people with advanced types of blood cancer (CMML or AML) who have run out of standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 105 participants will take part in this early-phase t…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for leukemia patients too frail for chemo: triple-drug combo shows promise
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) in people newly diagnosed with a specific type of leukemia (acute monocytic leukemia) who are not healthy enough for intensive chemotherapy. The goal is to see if this drug mix can put the canc…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC